FRAGMIN (dalteparin sodium) Contraindications

Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

FRAGMIN should not be used in patients who have the following:

  • Hypersensitivity to FRAGMIN or any of its constituents, including benzyl alcohol (when using the 25,000 IU multi-dose vial) (see WARNINGS AND PRECAUTIONS, Special Populations, Pregnant Women), or to other low molecular weight heparins (LMWHs) and/or heparin or pork products.
  • History of confirmed or suspected immunologically-mediated heparin-induced thrombocytopenia (delayed-onset severe thrombocytopenia), and/or in patients in whom an in vitro platelet-aggregation test in the presence of FRAGMIN is positive
  • Septic endocarditis (endocarditis lenta, acute or subacute endocarditis)
  • Uncontrollable active bleeding
  • Major blood clotting disorders
  • Acute gastroduodenal ulcer
  • Cerebral hemorrhage
  • Severe uncontrolled hypertension
  • Diabetic or hemorrhagic retinopathy
  • Other conditions or diseases involving an increased risk of hemorrhage
  • Injuries to and operations on the central nervous system, eyes, and ears
  • Spinal/epidural anesthesia is contraindicated where concomitant treatment with repeated high doses of FRAGMIN (100-120 IU/kg given twice daily or 200 IU/kg once daily, such as those needed to treat acute deep-vein thrombosis and unstable coronary artery disease) are required, due to an increased risk of bleeding